| 6.89 Data as of May 22 |  -0.05 / -0.72%Today’s Change | 4.00 Today|||52-Week Range 7.83 | +43.24% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $2.3B |
Company Description
OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company. The company is engaged in discovering, developing, commercializing and expertise its novel and proprietary technologies with a focus to provide unmet medical needs through a range of develops solutions to diagnose, treat and prevent various conditions, including molecular diagnostics, point-of-care tests and proprietary pharmaceuticals and vaccines. It operates through two reportable segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment consists of pharmaceutical research and development, which is focused on the research and development of pharmaceutical products, diagnostic tests and vaccines in Chile, Mexico and Israel. The Diagnostics segment consists of pathology operations and point-of-care and molecular diagnostics operations. OPKO Health was founded in October 1991 and is headquartered in Miami, FL.
Employees
Shareholders
| Other institutional | 8.21% |
| Individual stakeholders | 52.84% |
| Mutual fund holders | 5.98% |
Top Executives
| Phillip Frost, MD | Chairman & Chief Executive Officer |
| Juan F. Rodriguez, CPA | Chief Financial Officer & Senior Vice President |
| Jane H. Hsiao, PhD, MBA | Vice Chairman & Chief Technology Officer |
| Steven D. Rubin | Director & Executive Vice President-Administration |
| Adam E. Logal | Treasurer, Chief Accounting Officer & VP |
.
